Paclitax 300 mg Injection

Aprazer Healthcar e

Core Values of the company is to make quality

Healthcare products for all segments of society at affordable prices

Our Comapny

Aprazer Healthcare Private Limited, founded in 2017 in India, epitomizes a steadfast commitment to delivering high-quality and affordable medicines to all segments of society. At Aprazer Healthcare, our mission is deeply fixed in the belief that access to essential healthcare should be universal, regardless of economic status or geographic location.

Specializing in lifesaving drugs across diverse therapeutic segments, including Oncology, Hepatology, Gastroenterology, and HIV, Aprazer Healthcare addresses critical healthcare needs with a comprehensive range of pharmaceutical solutions. Our commitment to innovation extends beyond product development to encompass novel approaches in healthcare delivery and patient support services.

Paclikast-300

Paclitax 300 mg Injection is an anti-cancer medication utilized in the treatment of various cancers including breast cancer, pancreatic cancer, and non-small cell lung cancer. Administered via injection by a trained medical professional, the dosage and duration of therapy are determined by your doctor based on your specific condition and may be adjusted over time. It is imperative to adhere strictly to your doctor's instructions regarding the usage of this medication, as improper administration or excessive intake may lead to severe adverse effects.

Product Specification

Paclikast Manufacturer Aprazer

Treatment cancer Form

Injection